0001179110-17-012027.txt : 20170905 0001179110-17-012027.hdr.sgml : 20170904 20170905193209 ACCESSION NUMBER: 0001179110-17-012027 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170831 FILED AS OF DATE: 20170905 DATE AS OF CHANGE: 20170905 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Malkani Sanjay CENTRAL INDEX KEY: 0001571523 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16789 FILM NUMBER: 171069971 MAIL ADDRESS: STREET 1: 51 SAWYER ROAD, SUITE 200 CITY: WALTHAM STATE: MA ZIP: 02453 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALERE INC. CENTRAL INDEX KEY: 0001145460 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 043565120 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 51 SAWYER ROAD STREET 2: SUITE 200 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7816473900 MAIL ADDRESS: STREET 1: 51 SAWYER ROAD STREET 2: SUITE 200 CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: INVERNESS MEDICAL INNOVATIONS INC DATE OF NAME CHANGE: 20010720 4 1 edgar.xml FORM 4 - X0306 4 2017-08-31 0 0001145460 ALERE INC. ALR 0001571523 Malkani Sanjay 51 SAWYER ROAD, SUITE 200 WALTHAM MA 02453 0 1 0 0 Global Pres., Toxicology Common Stock 2017-08-31 4 M 0 6667 A 30795 D Common Stock 2017-08-31 4 F 0 2038 49.46 D 28757 D Common Stock 565 I See footnote 4. Restricted Stock Units 2017-08-31 4 M 0 6667 0 D Common Stock 6667 0 D Each restricted stock unit represents a contingent right to receive one share of Alere common stock. On August 31, 2014, the reporting person was granted 20,000 restricted stock units, which vest as follows: 6,666 on the first anniversary of the grant date (8/31/15); 6,667 on the second anniversary of the grant date (8/31/16); and 6,667 on the third anniversary of the grant date (8/31/17). These securities are owned by the reporting person's spouse. The reporting person hereby disclaims ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for the purpose of Section 16. /s/ Douglas Barry, Attorney-in-Fact 2017-09-05